As of 2021, there were **** deaths per 100 hospital admissions for stroke among those aged 45 years and older in Latvia. The statistic shows the thirty-day mortality after admission to hospital for ischaemic stroke in selected OECD countries as of 2021, per 100 admissions among adults aged 45 years and older.

Background: Under-five mortality remains concentrated in resource-poor countries. Post-discharge mortality is becoming increasingly recognized as a significant contributor to overall child mortality. With a substantial recent expansion of research and novel data synthesis methods, this study aims to update the current evidence base by providing a more nuanced understanding of the burden and associated risk factors of pediatric post-discharge mortality after acute illness. Methods: Eligible studies published between January 1, 2017 and January 31, 2023, were retrieved using MEDLINE, Embase, and CINAHL databases. Studies published before 2017 were identified in a previous review and added to the total pool of studies. Only studies from countries with low or low-middle Socio-Demographic Index with a post-discharge observation period greater than seven days were included. Risk of bias was assessed using a modified version of the Joanna Briggs Institute critical appraisal tool for prevalence studies. Studies were grouped by patient population, and 6-month post-discharge mortality rates were quantified by random-effects meta-analysis. Secondary outcomes included post-discharge mortality relative to in-hospital mortality, pooled risk factor estimates, and pooled post-discharge Kaplan–Meier survival curves. PROSPERO study registration: #CRD42022350975. Findings: Of 1963 articles screened, 42 eligible articles were identified and combined with 22 articles identified in the previous review, resulting in 64 total articles. These articles represented 46 unique patient cohorts and included a total of 105,560 children. For children admitted with a general acute illness, the pooled risk of mortality six months post-discharge was 4.4% (95% CI: 3.5%–5.4%, I2 = 94.2%, n = 11 studies, 34,457 children), and the pooled in-hospital mortality rate was 5.9% (95% CI: 4.2%–7.7%, I2 = 98.7%, n = 12 studies, 63,307 children). Among disease subgroups, severe malnutrition (12.2%, 95% CI: 6.2%–19.7%, I2 = 98.2%, n = 10 studies, 7760 children) and severe anemia (6.4%, 95% CI: 4.2%–9.1%, I2 = 93.3%, n = 9 studies, 7806 children) demonstrated the highest 6-month post-discharge mortality estimates. Diarrhea demonstrated the shortest median time to death (3.3 weeks) and anemia the longest (8.9 weeks). Most significant risk factors for post-discharge mortality included unplanned discharges, severe malnutrition, and HIV seropositivity. Interpretation: Pediatric post-discharge mortality rates remain high in resource-poor settings, especially among children admitted with malnutrition or anemia. Global health strategies must prioritize this health issue by dedicating resources to research and policy innovation. Data Processing Methods: Data were extracted using a standard data extraction form developed by the review authors. Kaplan–Meier survival curves, where provided, were extracted using a plot digitizer. The data extraction file, “PDMSR2024_DataExtraction_Dataset_SD” was generated as described above and analyzed as is. Co-ordinates were extracted from the survival curves in their original, published form, using a plot digitizer (https://automeris.io/WebPlotDigitizer/). The co-ordinates for each survival curve were then cleaned up to: 1. Re-scale the time points to weeks 2. Curves which reported % mortality were converted to % survival (1 – mortality) 3. First co-ordinate was set to (0, 1), i.e., survival is 100% at time-point 0 4. Include the numbers at risk (if reported), primary reference, and subgroup information Using these cleaned co-ordinates, individual-level patient data were extracted (see Guyot et al, 2012, doi.org/10.1186/1471-2288-12-9) and the survival curves re-constructed to obtain the survival and number at risk at specified time-points (0-52 weeks). Where possible, disease and age subgroups were combined to create all admissions curves by combining the individual-level patient data from multiple curves in the same study. Additional data from the survival curves were extracted to produce the “PDMSR2024_AdditionalDataSurvivalCurves6M_Dataset_SD” and “PDMSR2024_AdditionalDataSurvivalCurves12M_Dataset_SD” files by extracting the survival rate at 6 and 12 months. Previously unpublished hazards ratios were extracted from the dataset used in the Wiens et al (2015) study on post-discharge mortality (doi:10.1136/bmjopen-2015-009449) to produce the “PDMSR2024_Wiens2015HazardsRatios_Dataset_SD.xlsx” file. These original data are published on Dataverse at: doi.org/10.5683/SP2/VBPLRM Analyses were in R version 4.3.0 (R Foundation for Statistical Computing, Vienna, Austria), and RStudio version 2023.6.1 (RStudio, Boston, MA). Additional Files: Survival curves in their original, published form, as well as survival curve coordinates files can be made available by request. NOTE for restricted files: If you are not yet a CoLab member, please complete our membership application survey to gain access to restricted files within 2 business...

This dataset is about countries per year in Burkina Faso. It has 64 rows. It features 4 columns: country, hospital beds, and suicide mortality rate.

COVID-19 rate of death, or the known deaths divided by confirmed cases, was over ten percent in Yemen, the only country that has 1,000 or more cases. This according to a calculation that combines coronavirus stats on both deaths and registered cases for 221 different countries. Note that death rates are not the same as the chance of dying from an infection or the number of deaths based on an at-risk population. By April 26, 2022, the virus had infected over 510.2 million people worldwide, and led to a loss of 6.2 million. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. Note that Statista aims to also provide domestic source material for a more complete picture, and not to just look at one particular source. Examples are these statistics on the confirmed coronavirus cases in Russia or the COVID-19 cases in Italy, both of which are from domestic sources. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

A word on the flaws of numbers like this

People are right to ask whether these numbers are at all representative or not for several reasons. First, countries worldwide decide differently on who gets tested for the virus, meaning that comparing case numbers or death rates could to some extent be misleading. Germany, for example, started testing relatively early once the country’s first case was confirmed in Bavaria in January 2020, whereas Italy tests for the coronavirus postmortem. Second, not all people go to see (or can see, due to testing capacity) a doctor when they have mild symptoms. Countries like Norway and the Netherlands, for example, recommend people with non-severe symptoms to just stay at home. This means not all cases are known all the time, which could significantly alter the death rate as it is presented here. Third and finally, numbers like this change very frequently depending on how the pandemic spreads or the national healthcare capacity. It is therefore recommended to look at other (freely accessible) content that dives more into specifics, such as the coronavirus testing capacity in India or the number of hospital beds in the UK. Only with additional pieces of information can you get the full picture, something that this statistic in its current state simply cannot provide.

Background: In 2019, 80% of the 7.4 million global child deaths occurred in low- and middle-income countries (LMICs). Global and regional estimates of cause of hospital death and admission in LMIC children are needed to guide global and local priority setting and resource allocation but are currently lacking. The study objective was to estimate global and regional prevalence for common causes of pediatric hospital mortality and admission in LMICs. Methods: We performed a systematic review and meta-analysis to identify LMIC observational studies published January 1, 2005-February 26, 2021. Eligible studies included: a general pediatric admission population, a cause of admission or death, and total admissions. We excluded studies with data before 2000 or without a full text. Two authors independently screened and extracted data. We performed methodological assessment using domains adapted from the Quality in Prognosis Studies tool. Data were pooled using random-effects models where possible. We reported prevalence as a proportion of cause of death or admission per 1000 admissions with 95% confidence intervals (95%CI). Findings: ur search identified 29,637 texts. After duplicate removal and screening, we analyzed 253 studies representing 21.8 million pediatric hospitalizations in 59 LMICs. All-cause pediatric hospital mortality was 4.1% [95%CI 3.4-4.7%]. The most common causes of mortality (deaths/1000 admissions) were infectious (12 [95%CI 9-14]); respiratory (9 [95%CI 5-13]); and gastrointestinal (9 [95%CI 6-11]). Common causes of admission (cases/1000 admissions) were respiratory (255 [95%CI 231-280]); infectious (214 [95%CI193-234]); and gastrointestinal (166 [95%CI 143-190]). We observed regional variation in estimates. Pediatric hospital mortality remains high in LMICs. Implications: Global child health efforts must include measures to reduce hospital mortality including basic emergency and critical care services tailored to the local disease burden. Resources are urgently needed to promote equity in child health research, support researchers, and collect high-quality data in LMICs to further guide priority setting and resource allocation. NOTE for restricted files: If you are not yet a CoLab member, please complete our membership application survey to gain access to restricted files within 2 business days. Some files may remain restricted to CoLab members. These files are deemed more sensitive by the file owner and are meant to be shared on a case-by-case basis. Please contact the CoLab coordinator at sepsiscolab@bcchr.ca or visit our website.

US Healthcare Readmissions and Mortality

Evaluating Hospital Performance

By Health [source]

About this dataset

This dataset contains detailed information about 30-day readmission and mortality rates of U.S. hospitals. It is an essential tool for stakeholders aiming to identify opportunities for improving healthcare quality and performance across the country. Providers benefit by having access to comprehensive data regarding readmission, mortality rate, score, measure start/end dates, compared average to national as well as other pertinent metrics like zip codes, phone numbers and county names. Use this data set to conduct evaluations of how hospitals are meeting industry standards from a quality and outcomes perspective in order to make more informed decisions when designing patient care strategies and policies

More Datasets

For more datasets, click here.

Featured Notebooks

• 🚨 Your notebook can be here! 🚨!

How to use the dataset

This dataset provides data on 30-day readmission and mortality rates of U.S. hospitals, useful in understanding the quality of healthcare being provided. This data can provide insight into the effectiveness of treatments, patient care, and staff performance at different healthcare facilities throughout the country.

In order to use this dataset effectively, it is important to understand each column and how best to interpret them. The ‘Hospital Name’ column displays the name of the facility; ‘Address’ lists a street address for the hospital; ‘City’ indicates its geographic location; ‘State’ specifies a two-letter abbreviation for that state; ‘ZIP Code’ provides each facility's 5 digit zip code address; 'County Name' specifies what county that particular hospital resides in; 'Phone number' lists a phone contact for any given facility ;'Measure Name' identifies which measure is being recorded (for instance: Elective Delivery Before 39 Weeks); 'Score' value reflects an average score based on patient feedback surveys taken over time frame listed under ' Measure Start Date.' Then there are also columns tracking both lower estimates ('Lower Estimate') as well as higher estimates ('Higher Estimate'); these create variability that can be tracked by researchers seeking further answers or formulating future studies on this topic or field.; Lastly there is one more measure oissociated with this set: ' Footnote,' which may highlight any addional important details pertinent to analysis such as numbers outlying National averages etc..

This data set can be used by hospitals, research facilities and other interested parties in providing inciteful information when making decisions about patient care standards throughout America . It can help find patterns about readmitis/mortality along county lines or answer questions about preformance fluctuations between different hospital locations over an extended amount of time. So if you are ever curious about 30 days readmitted within US Hospitals don't hesitate to dive into this insightful dataset!

Research Ideas

• Comparing hospitals on a regional or national basis to measure the quality of care provided for readmission and mortality rates.
• Analyzing the effects of technological advancements such as telemedicine, virtual visits, and AI on readmission and mortality rates at different hospitals.
• Using measures such as Lower Estimate Higher Estimate scores to identify systematic problems in readmissions or mortality rate management at hospitals and informing public health care policy

Acknowledgements

If you use this dataset in your research, please credit the original authors. Data Source

License

License: Dataset copyright by authors - You are free to: - Share - copy and redistribute the material in any medium or format for any purpose, even commercially. - Adapt - remix, transform, and build upon the material for any purpose, even commercially. - You must: - Give appropriate credit - Provide a link to the license, and indicate if changes were made. - ShareAlike - You must distribute your contributions under the same license as the original. - Keep intact - all notices that refer to this license, including copyright notices.

Columns

File: Readmissions_and_Deaths_-_Hospital.csv | Column name | Description | |:-------------------------|:---------------------------------------------------------------------------------------------------| | Hospital Name ...

This dataset is about countries per year in Zambia. It has 64 rows. It features 4 columns: country, hospital beds, and suicide mortality rate.

This dataset is compiled from the World Bank Open Data repository and provides a wide range of countrywise health, mortality, and population indicators spanning the years 2000–2025. The aim of creating this dataset is to bring together key global health statistics in a structured format that makes it easier for researchers, policymakers, and students to analyze trends, make comparisons, and draw insights.

The dataset was built to support research in public health, demographics, and sustainable development goals (SDGs). It contains indicators such as immunization coverage, sanitation access, drinking water services, health expenditures, hospital resources, disease incidence, mortality rates, fertility rates, HIV/AIDS data, maternal health, and many more. By providing this data in a single collection, the goal is to help users explore long-term global health patterns, identify disparities between rural and urban populations, and understand how healthcare systems affect life expectancy and mortality over time.

Abstract Background The effective management of patients with acute myocardial infarction (AMI) is time-dependent. Objectives To assess the impacts of the implementation of prehospital care on admission rates and mortality associated with AMI. Methods Retrospective, ecological study, which assessed data from the Brazilian Universal Health System, from all 853 municipalities of Minas Gerais, from 2008 to 2016. Excessive skewness of general and in-hospital mortality rates was smoothed using the empirical Bayes method. This study assessed the relationship between Mobile Emergency Care Service (SAMU) in each municipality and the following 3 outcomes: mortality rate due to AMI, AMI in-hospital mortality, and AMI hospitalization rate, using the Poisson hierarchical model. Rates were corrected by age structure and detrended by seasonality and temporal influences. A confidence interval of 95% was adopted. Results AMI mortality rates decreased throughout the study, on average 2% per year, with seasonal variation. AMI in-hospital mortality also showed a decreasing trend, from 13.81% in 2008 to 11.43% in 2016. SAMU implementation was associated with decreased AMI mortality (odds ratio [OR] = 0.967, 95% confidence interval [CI] 0.936 to 0.998) and AMI in-hospital mortality (OR = 0.914, 95% CI 0.845 to 0.986), with no relation with hospitalizations (OR = 1.003, 95% CI 0.927 to 1.083). Conclusion SAMU implementation was associated with a modest but significant decrease in AMI in-hospital mortality. This finding reinforces the key role of prehospital care in AMI care and the need for investments on this service to improve clinical outcomes in low- and middle-income countries.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

This dataset is about countries in Middle Africa. It has 10 rows. It features 3 columns: hospital beds, and suicide mortality rate.

Global Covid-19 Data

Global Covid-19 data on cases, deaths, vaccinations, and more

By Valtteri Kurkela [source]

About this dataset

The dataset is constantly updated and synced hourly to ensure up-to-date information. With over several columns available for analysis and exploration purposes, users can extract valuable insights from this extensive dataset.

Some of the key metrics covered in the dataset include:

1. Vaccinations: The dataset covers total vaccinations administered worldwide as well as breakdowns of people vaccinated per hundred people and fully vaccinated individuals per hundred people.

2. Testing & Positivity: Information on total tests conducted along with new tests conducted per thousand people is provided. Additionally, details on positive rate (percentage of positive Covid-19 tests out of all conducted) are included.

3. Hospital & ICU: Data on ICU patients and hospital patients are available along with corresponding figures normalized per million people. Weekly admissions to intensive care units and hospitals are also provided.

4. Confirmed Cases: The number of confirmed Covid-19 cases globally is captured in both absolute numbers as well as normalized values representing cases per million people.

5.Confirmed Deaths: Total confirmed deaths due to Covid-19 worldwide are provided with figures adjusted for population size (total deaths per million).

6.Reproduction Rate: The estimated reproduction rate (R) indicates the contagiousness of the virus within a particular country or region.

7.Policy Responses: Besides healthcare-related metrics, this comprehensive dataset includes policy responses implemented by countries or regions such as lockdown measures or travel restrictions.

8.Other Variables of InterestThe data encompasses various socioeconomic factors that may influence Covid-19 outcomes including population density,membership in a continent,gross domestic product(GDP)per capita;

For demographic factors: -Age Structure : percentage populations aged 65 and older,aged (70)older,median age -Gender-specific factors: Percentage of female smokers -Lifestyle-related factors: Diabetes prevalence rate and extreme poverty rate

1. Excess Mortality: The dataset further provides insights into excess mortality rates, indicating the percentage increase in deaths above the expected number based on historical data.

The dataset consists of numerous columns providing specific information for analysis, such as ISO code for countries/regions, location names,and units of measurement for different parameters.

Overall,this dataset serves as a valuable resource for researchers, analysts, and policymakers seeking to explore various aspects related to Covid-19

How to use the dataset

Introduction:

• Understanding the Basic Structure:

  • The dataset consists of various columns containing different data related to vaccinations, testing, hospitalization, cases, deaths, policy responses, and other key variables.
  • Each row represents data for a specific country or region at a certain point in time.

• Selecting Desired Columns:

  • Identify the specific columns that are relevant to your analysis or research needs.
  • Some important columns include population, total cases, total deaths, new cases per million people, and vaccination-related metrics.

• Filtering Data:

  • Use filters based on specific conditions such as date ranges or continents to focus on relevant subsets of data.
  • This can help you analyze trends over time or compare data between different regions.

• Analyzing Vaccination Metrics:

  • Explore variables like total_vaccinations, people_vaccinated, and people_fully_vaccinated to assess vaccination coverage in different countries.
  • Calculate metrics such as people_vaccinated_per_hundred or total_boosters_per_hundred for standardized comparisons across populations.

• Investigating Testing Information:

  • Examine columns such as total_tests, new_tests, and tests_per_case to understand testing efforts in various countries.
  • Calculate rates like tests_per_case to assess testing efficiency or identify changes in testing strategies over time.

• Exploring Hospitalization and ICU Data:

  • Analyze variables like hosp_patients, icu_patients, and hospital_beds_per_thousand to understand healthcare systems' strain.
  • Calculate rates like icu_patients_per_million or hosp_patients_per_million for cross-country comparisons.

• Assessing Covid-19 Cases and Deaths:

  • Analyze variables like total_cases, new_ca...

In 2018, over *** million people died due to poor quality of care in hospitals in the south Asian country of India. Furthermore, over *** people died due to insufficient access to healthcare in the country during that time.

IntroductionDespite the improvements in European health systems, a large number of premature deaths are attributable to treatable mortality. Men make up the majority of these deaths, with a significant gap existing between women and men’s treatable mortality rate in the EU.AimThis study aims to identify the healthcare-related factors, including health expenditures, human and physical resources, and hospital services use associated with treatable mortality in women and men across European countries during the period 2011–2019.MethodsWe use Eurostat data for 28 EU countries in the period 2011–2019. We estimate a panel data linear regression with country fixed effects and quantile linear regression for men and women.ResultsThe results found (i) differences in drivers for male and female treatable mortality, but common drivers hold the same direction for both sexes; (ii) favorable drivers are GDP per capita, health expenditures, number of physicians per capita, and (only for men) the average length of a hospital stay, (iii) unfavorable drivers are nurses and beds per capita, although nurses are not significant for explaining female mortality.ConclusionPolicy recommendations may arise that involve an improvement in hospital bed management and the design of more specific policies aimed at healthcare professionals.

Background: Substantial mortality occurs after hospital discharge in children younger than 5 years with suspected sepsis, especially in low-income countries. A better understanding of its epidemiology is needed for effective interventions to reduce child mortality in these countries. We evaluated risk factors for death after discharge in children admitted to hospital for suspected sepsis in Uganda, and assessed how these differed by age, time of death, and location of death. Methods: In this prospective observational cohort study, we recruited 0-60-month-old children admitted with suspected sepsis from the community to the paediatric wards of six Ugandan hospitals. The primary outcome was six-month post-discharge mortality among those discharged alive. We evaluated the interactive impact of age, time of death, and location of death on risk factors for mortality. Findings: 6,545 children were enrolled, with 6,191 discharged alive. The median (interquartile range) time from discharge to death was 28 (9-74) days, with a six-month post-discharge mortality rate of 5·5%, constituting 51% of total mortality. Deaths occurred at home (45%), in-transit to care (18%), or in hospital (37%) during a subsequent readmission. Post-discharge death was strongly associated with weight-for-age z-scores < -3 (adjusted risk ratio [aRR] 4·7, 95% CI 3·7–5·8 vs a Z score of >–2), referral for further care (7·3, 5·6–9·5), and unplanned discharge (3·2, 2·5–4·0). The hazard ratio of those with severe anaemia increased with time since discharge, while the hazard ratios of discharge vulnerabilities (unplanned, poor feeding) decreased with time. Age influenced the effect of several variables, including anthropometric indices (less impact with increasing age), anaemia (greater impact), and admission temperature (greater impact). Data Collection Methods: All data were collected at the point of care using encrypted study tablets and these data were then uploaded to a Research Electronic Data Capture (REDCap) database hosted at the BC Children’s Hospital Research Institute (Vancouver, Canada). At admission, trained study nurses systematically collected data on clinical, social and demographic variables. Following discharge, field officers contacted caregivers at 2 and 4 months by phone, and in-person at 6 months, to determine vital status, post-discharge health-seeking, and readmission details. Verbal autopsies were conducted for children who had died following discharge. Data Processing Methods: For this analysis, data from both cohorts (0-6 months and 6-60 months) were combined and analysed as a single dataset. We used periods of overlapping enrolment (72% of total enrolment months) between the two cohorts to determine site-specific proportions of children who were 0-6 and 6-60 months of age. These proportions were used to weight the cohorts for the calculation of overall mortality rate. Z-scores were calculated using height and weight. Hematocrit was converted to hemoglobin. Distance to hospital was calculated using latitude and longitude. Extra symptom and diagnosis categories were created based on text field in these two variables. BCS score was created by summing all individual components. Abbreviations: MUAC -mid upper arm circumference wfa – weight for age wfl – weight for length bmi – body mass index lfa – length for age abx - antibiotics hr – heart rate rr – respiratory rate antimal - antimalarial sysbp – systolic blood pressure diasbp – diastolic blood pressure resp – respiratory cap - capillary BCS - Blantyre Coma Scale dist- distance hos - hospital ed - education disch - discharge dis -discharge fu – follow-up pd – post-discharge loc - location materl - maternal Ethics Declaration: This study was approved by the Mbarara University of Science and Technology Research Ethics Committee (No. 15/10-16), the Uganda National Institute of Science and Technology (HS 2207), and the University of British Columbia / Children & Women’s Health Centre of British Columbia Research Ethics Board (H16-02679). This manuscript adheres to the guidelines for STrengthening the Reporting of OBservational studies in Epidemiology (STROBE). Study Protocol & Supplementary Materials: Smart Discharges to improve post-discharge health outcomes in children: A prospective before-after study with staggered implementation, NOTE for restricted files: If you are not yet a CoLab member, please complete our membership application survey to gain access to restricted files within 2 business days. Some files may remain restricted to CoLab members. These files are deemed more sensitive by the file owner and are meant to be shared on a case-by-case basis. Please contact the CoLab coordinator at sepsiscolab@bcchr.ca or visit our website.

A confidence interval: 95%.a The first hospital episode (FHE) starts at the day of birth and includes all continuous hospital days, including transfers between different hospitals.Risk adjusted average number of hospital days during FHE.a

Peru is the country with the highest mortality rate due to the coronavirus disease (COVID-19) in Latin America. As of November 13, 2023, the country registered over 672 deaths per 100,000 inhabitants. It was followed by Brazil, with around 331.5 fatal cases per 100,000 population. In total, over 1.76 million people have died due to COVID-19 in Latin America and the Caribbean.

Are these figures accurate? Although countries like Brazil already rank among the countries most affected by the coronavirus disease (COVID-19), there is still room to believe that the number of cases and deaths in Latin American countries are underreported. The main reason is the relatively low number of tests performed in the region. For example, Brazil, one of the most impacted countries in the world, has performed approximately 63.7 million tests as of December 22, 2022. This compared with over one billion tests performed in the United States, approximately 909 million tests completed in India, or around 522 million tests carried out in the United Kingdom.

Capacity to deal with the outbreak With the spread of the Omicron variant, the COVID-19 pandemic is putting health systems around the world under serious pressure. The lack of equipment to treat acute cases, for instance, is one of the problems affecting Latin American countries. In 2019, the number of ventilators in hospitals in the most affected countries ranged from 25.23 per 100,000 inhabitants in Brazil to 5.12 per 100,000 people in Peru.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

BackgroundSub-Saharan Africa has the highest rates of child mortality worldwide. Little is known about post-hospital outcomes after an index hospitalization for older children. We determined 12-month post-hospital mortality rate and identified factors associated with higher mortality.MethodsIn this prospective cohort study, we enrolled children 2–12 years of age admitted to the pediatric wards of two public hospitals in northwestern Tanzania. Participants or proxies were contacted at 3, 6 and 12 months post-hospitalization. The primary outcome measured was mortality. Factors associated with mortality were determined using Cox regression analysis.ResultsA total of 506 participants were enrolled. In-hospital mortality rate was 7.7% (39/506). Of the 467 participants discharged, the post-hospital mortality rate was 10.1% (47/467). Sickle cell disease (Hazard Ratio (HR) 3.32, 95% CI 1.44–7.68), severe malnutrition (HR 3.19, 95% CI 1.18–8.57), neurologic diseases (HR 3.51, 95% CI 1.35–9.11), heart disease (HR 7.11, 95% CI, 2.89–17.51), cancer (HR 11.79, 95% CI 4.95–28.03), and septic shock (HR 4.64, 95% CI 1.42–15.08) had higher association with mortality compared to other diagnoses. The risk factors significantly associated with mortality included older age (HR 1.01, 95% CI 1.00–1.08), lower hemoglobin level (HR 0.83, 95% CI 0.76–0.90), lower Glasgow Coma Scale (HR 0.66, 95% CI 0.59–0.74), history of decreased urine output (HR 2.87, 95% CI 1.49–5.53), higher respiratory rate (HR 1.02, 95% CI 1.00–1.03), estimated glomerular filtration rate less than 60 ml/min/1.73m2 (binary) (HR 1.84, 95% CI 1.10–3.10), and lower oxygen saturation (HR 0.96, 95% CI 0.92–0.99).ConclusionsPost-hospital mortality is disturbingly high among children 2–12 years of age in Tanzania. Post-hospital interventions are urgently needed especially for older children with chronic illnesses.

This scatter chart displays hospital beds (per 1,000 people) against suicide mortality rate (per 100,000 population) in Caribbean. The data is about countries.

SARS-Cov-2 detection, COVID-19 morbidity and mortality rates by selected country.